This article is provided for educational and informational purposes only. All compounds discussed are supplied strictly for laboratory and research use. Vitro Labs products are not for human or animal consumption.
A Certificate of Analysis is the only document standing between a researcher and a vial of unknown powder. For GHK-Cu. the copper-binding 3-amino-acid compound first described by Loren Pickart in the 1970s (Pickart & Thaler, 1973, PMID: 4703644). the COA has to answer a handful of specific questions before the vial goes on the shelf. Is the amino-acid sequence actually Gly-His-Lys? Is the copper actually complexed? Is it 99% pure or 92% pure, and what’s the other 8%? How much of the mass is compound versus counter-ion versus residual water?
Most researchers glance at a COA, see “≥98% purity,” and move on. That’s a mistake. The purity number alone doesn’t tell you what the impurities are, whether the copper is bound stoichiometrically, or whether the batch carries residual trifluoroacetic acid from synthesis. Those details matter for reproducibility in cell culture and analytical work, and they separate a rigorous reference standard from a nominally-similar one.
This walkthrough goes section by section through a real GHK-Cu Certificate of Analysis. the kind Vitro Labs ships with every batch, issued by Freedom Diagnostics, an ISO-certified independent analytical laboratory. The goal is to make every line of the document legible, so researchers evaluating a reference standard can tell in about ninety seconds whether a batch belongs in their laboratory inventory.
A Certificate of Analysis, or COA, is a lot-specific analytical report. It documents what a third-party laboratory measured on a specific batch of material. not what the manufacturer hopes is in the vial, and not a generic specification sheet copied from another lot. The distinction matters. A specification sheet is a target. A COA is a measurement.
For research-grade compounds, a legitimate COA carries a few unmistakable features. It names the lot or batch number. It names the testing laboratory, ideally an independent one. It lists the specific analytical methods used. HPLC, LC-MS, and so on. and reports numeric results with units. It’s dated. It’s signed or otherwise attributable to a specific analyst or laboratory.
What a COA is not: a marketing document. It doesn’t make claims about safety or efficacy. It doesn’t discuss dosing. It doesn’t compare the material to a pharmaceutical product. Those framings belong somewhere else. and if they show up on a COA, that’s the first sign the document is theater rather than analysis.
For a broader view of how Vitro Labs approaches editorial and analytical standards, see the Editorial Standards page. For live examples of the documents this article walks through, see the Certificates of Analysis archive.
Before we get into individual sections, it helps to remember what GHK-Cu actually is at the chemistry level, because the COA is structured around confirming those specific properties.
GHK is a 3-amino-acid compound: glycine–histidine–lysine (Gly-His-Lys). Its molecular formula is C14H24N6O4 and its molecular weight is 340.38 Da. On its own, it’s a small, water-soluble compound fragment found endogenously in human plasma at roughly 200 ng/mL in young adults, declining with age (Pickart et al., 2015, PMID: 26418782).
The “-Cu” part is what makes it interesting analytically. GHK binds divalent copper (Cu2+) with high affinity. the imidazole nitrogen of histidine, the alpha-amino nitrogen of glycine, and a deprotonated amide nitrogen all coordinate to a single copper ion, forming a stable, planar complex (Freedman et al., 1982, PMID: 6759520). That complex is what most preclinical GHK-Cu literature is actually studying.
When a supplier says a vial contains “GHK-Cu,” the COA has to demonstrate two things: the 3-amino-acid compound is present in the correct sequence, and the copper is complexed to it in the expected stoichiometry.
The top of a real COA is boring, and that’s a feature. It should include the compound name and supplier, a unique lot or batch identifier (something like VTR-GHKCU-2025-0417), the manufacture or analysis date, the testing laboratory’s name and address, and the analytical methods used. On a Vitro Labs COA, the testing laboratory line reads Freedom Diagnostics, Franklin, TN, and the lot number cross-references the physical vial label.
Match the lot number on the COA to the lot number printed on the vial. This sounds trivial. It isn’t. The most common vendor failure mode isn’t fabricating a COA. it’s serving the same COA for multiple lots, or a COA whose lot number doesn’t match the vial in the researcher’s hand. If those numbers don’t match, the document is describing a different batch.
The testing laboratory name also matters. An in-house COA. where the manufacturer tested its own product. is not the same evidentiary weight as an independent third-party COA. For the compliance and reproducibility posture most research settings expect, independent third-party testing is the baseline.
The identity section answers one question: is this actually the molecule on the label? For GHK-Cu, the answer comes from mass spectrometry, usually LC-MS. The instrument ionizes the sample and measures the mass-to-charge ratio (m/z) of the ions produced, which lets the analyst calculate the molecular weight of what’s in the vial.
The bare GHK 3-amino-acid compound has a monoisotopic mass of 340.18 Da and an average molecular weight of 340.38 Da. In positive ionization mode, the analyst typically sees the [M+H]+ peak at 341.19 m/z. the compound plus one proton.
The copper complex adds one atom of copper (average atomic weight ≈ 63.55, though the natural abundance produces a characteristic 63Cu / 65Cu isotope pattern) and typically involves loss of protons from the coordination sites. The mass spectrum of GHK-Cu shows the copper isotope signature. a doublet with roughly a 2:1 intensity ratio, spaced by two mass units. which is a fingerprint no non-copper impurity can fake.
A well-formatted identity section reports the observed m/z, the theoretical m/z, and the mass accuracy in parts per million (ppm) or Daltons. For a small 3-amino-acid compound on a modern LC-MS instrument, mass accuracy under 5 ppm is unremarkable and expected. If the observed mass is 341.2 ± 0.5 Da for the [M+H]+ of GHK, and the copper isotope pattern is visible in the GHK-Cu spectrum, the identity is confirmed.
If the reported mass is off by more than a few Daltons, or the copper isotope pattern is missing from a batch labeled as GHK-Cu, the identity is not confirmed regardless of what the certificate says at the top.
HPLC purity is the number most researchers actually look at, and it deserves more attention than a single percentage. The measurement works by injecting a small amount of the compound onto a reversed-phase column, running a solvent gradient, and detecting compounds as they elute. Each compound produces a peak. The area under the main peak, divided by the total area of all peaks, gives the purity percentage.
A reported “HPLC purity ≥98%” means that 98% of the UV-absorbing material eluting from the column is the target compound, and 2% is something else. That “something else” could be a synthesis-related impurity. a truncated sequence missing one amino acid, an oxidized side chain, an incompletely deprotected residue. or it could be a degradation product from storage.
The critical detail: HPLC purity is a relative measurement of what elutes from the column. It does not account for non-compound mass like water, counter-ion, or inorganic salt. A batch can read 99.2% pure by HPLC and still be only 82% compound by weight, because the other 18% is water and acetate that don’t show up on the UV detector. That’s the difference between HPLC purity and net compound content, which is the next section.
A well-annotated COA includes the actual chromatogram trace, not just the summary number. The features to look for:
For GHK-Cu specifically, one wrinkle: on a standard reversed-phase HPLC method, the free compound and the copper complex may or may not co-elute, depending on mobile phase conditions. Some COAs report HPLC purity on the compound portion after copper dissociation. Others report it on the intact complex. Both are legitimate. but the method note should say which.
Net compound content is the answer to the question “how many milligrams of actual compound are in this vial?” It’s usually reported as a percentage. say, 82% net compound content. and it’s almost always lower than the HPLC purity number for the same batch. Understanding why is essential to using a COA correctly.
A lyophilized compound vial labeled “50 mg GHK-Cu” contains, by mass, four things:
Net compound content is determined by amino acid analysis (AAA) or a related quantitative method. It represents the actual compound mass fraction. For a well-manufactured GHK-Cu, net compound content in the 78–88% range is typical when using acetate counter-ion. The remainder is counter-ion mass plus a few percent water and trace salts.
If a research protocol calls for reconstitution to a specific molar concentration, the calculation has to use net compound content, not HPLC purity. A researcher who weighs out 5 mg of “98% pure GHK-Cu” and dissolves it assuming 98% compound will be overestimating the compound concentration by about 15%. That’s the difference between a 100 µM working solution and an 85 µM working solution. enough to matter in a dose-response experiment.
“Compound content, as determined by quantitative amino acid analysis, is the most reliable measure of the actual compound mass in a lyophilized preparation.”
, Rutherfurd & Gilani (2009), Current Protocols in Protein Science, PMID: 19365791
Compounds synthesized by solid-phase methods come off the resin with acid impurities from the cleavage cocktail. The most common is trifluoroacetic acid (TFA). Manufacturers then either leave the TFA in place or exchange it for a milder counter-ion, most often acetate. The counter-ion is charge-balancing whatever basic side chains the compound carries. in GHK, the lysine and histidine side chains are protonatable, so counter-ion is always present in some amount.
For most analytical uses, either counter-ion is chemically acceptable. But TFA is not inert in cell culture. Cornish and colleagues (1999) reported that residual TFA in compound preparations produced measurable perturbations in cultured mammalian cells at low micromolar concentrations. enough to confound signaling studies (Cornish et al., 1999, PMID: 10419789). For downstream cellular research, acetate counter-ion is generally preferred, and most reputable suppliers of research-grade compounds intended for cell work perform an ion-exchange step to remove TFA.
A rigorous COA reports the counter-ion identity and, ideally, its mass percentage. “Acetate: 8.2%” tells the researcher two things: the TFA has been exchanged out, and roughly 8% of the vial’s mass is acetate rather than compound. That number feeds directly into the net compound content calculation.
If the COA doesn’t mention counter-ion at all, the batch is almost certainly TFA salt by default. because that’s what comes off the synthesis without further processing. That’s not automatically disqualifying, but it’s a data point the researcher should know before requisitioning.
| Property | Acetate salt | TFA salt |
|---|---|---|
| Typical mass contribution | 5–12% | 10–20% |
| Cell culture interference | Minimal at typical concentrations | Documented at low µM (Cornish 1999) |
| Requires ion-exchange step | Yes. costs more | No. default after synthesis |
| COA disclosure standard | Reported with % | Often omitted |
A lyophilized compound is freeze-dried, but “freeze-dried” doesn’t mean “anhydrous.” Residual water in a lyophilized vial typically ranges from 2% to 6% by mass, measured by Karl Fischer titration or thermogravimetric analysis. That water is a real part of the vial mass and part of what net compound content accounts for.
Residual solvents are the trace organics left over from synthesis and purification. most commonly acetonitrile from HPLC purification, and dimethylformamide (DMF) or dichloromethane (DCM) from the coupling and cleavage steps. Analytical laboratories quantify these by gas chromatography, usually against the International Council for Harmonisation’s Q3C thresholds for residual solvents (ICH Q3C, class-based limits).
On a research-grade COA, residual solvents should either be reported as “below detection limit” for the relevant class-2 and class-3 solvents, or reported with actual numeric values. “Complies with ICH Q3C” without numbers is less informative but still meaningful.
Endotoxin testing measures bacterial lipopolysaccharide contamination in a compound preparation. In pharmaceutical manufacturing intended for parenteral use, endotoxin testing is a standard component of the analytical package, performed by LAL assay or a recombinant equivalent.
In the research-compound category, endotoxin testing is inconsistently offered across suppliers, and researchers evaluating a COA should look at what the specific certificate actually reports. Vitro Labs’ certificates report the fields the analytical package covers: identity by LC-MS, purity by HPLC-UV, net content, appearance, and the method used. Endotoxin testing is not among the fields Vitro Labs represents on its analytical package.
The point of naming this section is educational: researchers should know what endotoxin testing is, what it measures, and how it’s reported in industry documentation. so they can accurately evaluate any supplier’s package. For applications where endotoxin content is critical, acquirers should look for a supplier that specifically documents that test on their certificates. Product Terms include the standard disclaimer that materials are not represented as sterile, pyrogen-free, or endotoxin-free unless explicitly stated in writing.
This is the section that separates a GHK COA from a GHK-Cu COA. The 3-amino-acid compound alone (Gly-His-Lys) has a well-defined structure. The copper complex adds a second characterization requirement: the copper has to be there, and it has to be there in the expected 1:1 molar ratio with the compound.
Two approaches are common. Inductively coupled plasma mass spectrometry (ICP-MS) or ICP-OES quantifies the total copper in the sample directly. UV-visible spectroscopy takes advantage of a specific optical property: the GHK-Cu complex absorbs at around 525 nm with a characteristic molar extinction coefficient, and the intensity of that absorbance tracks the amount of copper bound to compound (Freedman et al., 1982, PMID: 6759520).
For a 50 mg vial of GHK-Cu with 1:1 stoichiometry, expected copper content is roughly 15–17% by mass of the compound-copper portion. the copper atomic weight (~63.5) divided by the complex molecular weight (~403). Deviations from that range suggest either incomplete copper loading (under-copper) or excess free copper salt (over-copper), both of which affect what’s actually in the vial.
“Copper content: 15.8% ± 0.3% (ICP-MS)” is what a specific, verifiable result looks like. “Contains copper” is not. If the COA just asserts copper is present without quantifying it, the researcher can’t tell whether they’re getting stoichiometric complex, sub-stoichiometric compound-plus-a-little-copper, or compound with an unrelated copper salt mixed in.
The last field on most COAs is the simplest and easiest to verify at the bench. A well-manufactured lyophilized GHK-Cu preparation is described as a fine, uniform blue or blue-violet powder or cake. The color is diagnostic: the copper-compound complex produces the blue color at visible wavelengths, and the intensity of the color loosely tracks with copper loading.
A white or off-white powder labeled “GHK-Cu” is a serious flag. The 3-amino-acid compound alone is essentially colorless as a lyophilized powder. If the vial contents don’t show the characteristic blue coloration, either the copper isn’t there or it’s not complexed to the compound. In either case, the vial is not what the label claims.
Vitro Labs’ GHK-Cu 50mg (see product reference page) is characterized as a blue lyophilized powder on the analytical package. Researchers receiving the vial should visually confirm the color before reconstitution.
⚗️ Research Disclaimer: All content on this page is intended exclusively for licensed researchers, academic institutions, and scientific professionals operating within approved laboratory settings. GHK-Cu is a research compound not approved for human clinical use by the FDA or equivalent regulatory authorities. This content does not constitute medical advice, clinical guidance, or a recommendation for use in humans or animals outside of approved research protocols. All materials discussed are for laboratory research use only and are not approved for human consumption.
Working backward from the sections above, a few specific patterns should trigger skepticism when evaluating a certificate.
Multiple vials shipped from the same supplier with different production dates all referencing the same COA is a durable indicator that the document isn’t lot-specific. Lot numbers should change every batch. Analysis dates should change every batch. If they don’t, the document has become a specification sheet, not a measurement.
A COA that reports “HPLC purity ≥98%” and stops there is not enough information to plan a quantitative experiment. Rigorous certificates include net compound content, counter-ion identity and percentage, and residual water content. the three fields that together explain the difference between the vial’s total mass and its actual compound mass.
A COA for “GHK-Cu” that doesn’t quantify copper content by ICP-MS, ICP-OES, or UV-visible spectroscopy is characterizing GHK, not GHK-Cu. The most rigorous certificates report copper as a percentage and reference the analytical method.
Manufacturer-run analysis is not the same evidentiary weight as third-party testing. The most reliable pattern for research supply is: manufacturer produces the batch, and an ISO-certified independent analytical laboratory characterizes it. That separation of production and analysis is what makes the numbers meaningful.
Real COAs from real analytical laboratories include instrument-generated chromatograms and mass spectra as figures or attachments, not just summary tables. A one-page PDF with only summary numbers and no figures is characteristic of an in-house specification sheet, not an analytical report.
Every batch of GHK-Cu that Vitro Labs supplies is characterized by Freedom Diagnostics, an ISO-certified analytical laboratory based in Franklin, Tennessee. Independent third-party testing is the standard the compliance and reproducibility posture of most research settings expect, and it’s the structural feature that makes a COA an evidentiary document rather than a marketing one.
Vitro Labs’ analytical package covers the fields the certificate lists: identity by LC-MS, purity by HPLC-UV, net compound content, physical appearance, and the analytical methods used. Those are the fields Vitro represents. Any additional testing a specific researcher’s application requires. endotoxin quantification for cell culture at defined thresholds, sterility testing for a specific downstream use. should be verified against the batch-specific certificate before the material enters laboratory inventory.
For an archive of representative certificates, see the Certificates of Analysis page. For the broader editorial and analytical standards Vitro Labs operates under, see Editorial Standards.
⚠️ Research Disclaimer: This article is for educational and informational purposes only. All compounds discussed are research chemicals for laboratory use only and are not for human consumption. Statements have not been evaluated by the FDA. Materials are not intended to diagnose, treat, cure, or prevent any disease.
HPLC purity is a relative measurement: it reports the percentage of UV-absorbing material eluting from a chromatography column that is the target compound, versus other UV-absorbing impurities. Net compound content is a mass measurement: it reports the percentage of the total dry weight of the vial that is actually compound, with the remainder being counter-ion, residual water, and trace salts. A batch can be 98% pure by HPLC and only 82% compound by mass. Quantitative amino acid analysis is the standard method for determining net compound content (Rutherfurd & Gilani, 2009, PMID: 19365791). For calculating molar concentrations during reconstitution in research models, net compound content is the correct number to use, not HPLC purity.
Two analytical approaches are standard. Inductively coupled plasma mass spectrometry (ICP-MS) or ICP-OES directly quantifies total copper content in the sample by atomic-level detection. UV-visible spectroscopy takes advantage of a specific optical property of the GHK-Cu complex: it absorbs at approximately 525 nm with a characteristic molar extinction coefficient, and the intensity of that absorbance tracks the amount of copper bound to compound (Freedman et al., 1982, PMID: 6759520). For a 1:1 GHK-to-copper stoichiometry, copper content typically falls in the range of 15–17% by mass of the compound-copper portion. A COA characterizing GHK-Cu should report copper content as a numeric percentage rather than a qualitative statement, along with the analytical method used.
Compounds synthesized by solid-phase methods come off the resin as trifluoroacetate (TFA) salts. Manufacturers can either leave the TFA in place or exchange it for a milder counter-ion, most commonly acetate. Cornish and colleagues (1999) reported that residual TFA in compound preparations produced measurable perturbations in cultured mammalian cells at low micromolar concentrations, enough to confound cellular signaling studies (PMID: 10419789). For research applications involving cell culture, acetate counter-ion is generally preferred to avoid TFA-related artifacts. A rigorous COA reports the counter-ion identity and mass percentage. If the COA does not mention counter-ion, the batch is likely TFA salt by default, since that is the direct output of solid-phase synthesis without further processing.
ISO certification, most commonly ISO/IEC 17025 for testing and calibration laboratories, is an international standard specifying general requirements for the competence, impartiality, and consistent operation of laboratories. An ISO-certified analytical laboratory has documented procedures for calibrating instruments, validating methods, training analysts, and handling samples, with periodic third-party audits verifying compliance. For a research-compound certificate, ISO certification of the testing laboratory means the analytical results were produced under a documented quality system, rather than by ad-hoc measurement. The certification does not directly certify the compound product; it certifies the laboratory that measured it. Vitro Labs partners with Freedom Diagnostics, an ISO-certified independent analytical laboratory, for third-party characterization of each batch.
A well-manufactured lyophilized GHK-Cu preparation appears as a fine, uniform blue or blue-violet powder or cake. The color arises from the copper-compound complex, which absorbs light in the visible spectrum around 525 nm. a property that also underlies the UV-visible spectroscopy method for quantifying copper content (Freedman et al., 1982, PMID: 6759520). The 3-amino-acid compound alone, without copper, is essentially colorless as a lyophilized powder. A white or off-white powder labeled GHK-Cu is a serious flag: either the copper is absent or it is not complexed to the compound. Visual color confirmation before reconstitution is a quick, low-effort verification step that complements the analytical data on the COA.
Endotoxin testing is a standard component of the analytical package in pharmaceutical manufacturing intended for parenteral use, performed by Limulus Amebocyte Lysate (LAL) assay or a recombinant equivalent. In the research-compound category, endotoxin testing is inconsistently offered across suppliers, and the appropriate expectation depends on the specific supplier’s stated analytical package. Vitro Labs’ certificates report identity by LC-MS, purity by HPLC-UV, net compound content, appearance, and the method used. Endotoxin testing is not among the fields Vitro Labs represents on its analytical package, and products are not represented as sterile, pyrogen-free, or endotoxin-free unless explicitly stated in writing. For applications where endotoxin content is critical, researchers should verify the specific supplier’s certificate explicitly documents endotoxin testing before adding material to inventory.
⚗️ Research Disclaimer: All content on this page is intended exclusively for licensed researchers, academic institutions, and scientific professionals operating within approved laboratory settings. GHK-Cu is a research compound not approved for human clinical use by the FDA or equivalent regulatory authorities. This content does not constitute medical advice, clinical guidance, or a recommendation for use in humans or animals outside of approved research protocols. All materials discussed are for laboratory research use only and are not approved for human consumption.
